{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:06:13Z","timestamp":1792087573032,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03332-6","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:25:18Z","timestamp":1760617518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transcriptional activation of MACF1 by NR2F1 drives WNT-mediated focal adhesion and metastasis in lung adenocarcinoma"],"prefix":"10.1186","volume":"30","author":[{"given":"Yi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangcheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"1","key":"3332_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","volume":"18","author":"PL Su","year":"2025","unstructured":"Su PL, et al. Recent advances in therapeutic strategies for non-small cell lung cancer. J Hematol Oncol. 2025;18(1):35.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3332_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-025-02245-6","volume":"24","author":"Z Xi","year":"2025","unstructured":"Xi Z, et al. Traditional Chinese medicine in lung cancer treatment. Mol Cancer. 2025;24(1):57.","journal-title":"Mol Cancer"},{"issue":"10","key":"3332_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35849","volume":"131","author":"C Dennehy","year":"2025","unstructured":"Dennehy C, Conroy MR, Forde PM. Immunotherapy for resectable lung cancer. Cancer. 2025;131(10):e35849.","journal-title":"Cancer"},{"issue":"1","key":"3332_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00408-025-00801-x","volume":"203","author":"H Jeon","year":"2025","unstructured":"Jeon H, et al. Update 2025: management of non-small-cell lung cancer. Lung. 2025;203(1):53.","journal-title":"Lung"},{"key":"3332_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32030146","author":"N Bouchard","year":"2025","unstructured":"Bouchard N, Daaboul N. Lung cancer: Targeted therapy in 2025. Curr Oncol. 2025. https:\/\/doi.org\/10.3390\/curroncol32030146.","journal-title":"Curr Oncol"},{"issue":"6","key":"3332_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41568-025-00803-0","volume":"25","author":"KL Simpson","year":"2025","unstructured":"Simpson KL, et al. Challenges of small cell lung cancer heterogeneity and phenotypic plasticity. Nat Rev Cancer. 2025;25(6):447\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3332_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox TR. The matrix in cancer. Nat Rev Cancer. 2021;21(4):217\u201338.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3332_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","volume":"7","author":"M Zhao","year":"2022","unstructured":"Zhao M, et al. Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct Target Ther. 2022;7(1):206.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3332_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/prd.12540","volume":"96","author":"G Baima","year":"2024","unstructured":"Baima G, et al. Periodontitis and risk of cancer: mechanistic evidence. Periodontol 2000. 2024;96(1):83\u201394.","journal-title":"Periodontol 2000"},{"issue":"9","key":"3332_CR10","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, et al. The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B. 2021;11(9):2783\u201397.","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"3332_CR11","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.apsb.2021.01.004","volume":"11","author":"M Li","year":"2021","unstructured":"Li M, et al. Integrins as attractive targets for cancer therapeutics. Acta Pharm Sin B. 2021;11(9):2726\u201337.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3332_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.apsb.2017.11.005","volume":"8","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Sun T, Jiang C. Biomacromolecules as carriers in drug delivery and tissue engineering. Acta Pharm Sin B. 2018;8(1):34\u201350.","journal-title":"Acta Pharm Sin B"},{"key":"3332_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.matbio.2018.02.018","volume":"73","author":"M G\u00f6tte","year":"2018","unstructured":"G\u00f6tte M, Kovalszky I. Extracellular matrix functions in lung cancer. Matrix Biol. 2018;73:105\u201321.","journal-title":"Matrix Biol"},{"key":"3332_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2017.05.017","volume":"69","author":"L Hu","year":"2017","unstructured":"Hu L, et al. MACF1, versatility in tissue-specific function and in human disease. Semin Cell Dev Biol. 2017;69:3\u20138.","journal-title":"Semin Cell Dev Biol"},{"key":"3332_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.semcdb.2017.05.020","volume":"69","author":"JJ Moffat","year":"2017","unstructured":"Moffat JJ, et al. The role of MACF1 in nervous system development and maintenance. Semin Cell Dev Biol. 2017;69:9\u201317.","journal-title":"Semin Cell Dev Biol"},{"key":"3332_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073204","author":"CM Lin","year":"2025","unstructured":"Lin CM, Fu RH, Chen HJ. A multifaceted giant protein microtubule-actin cross-linking factor 1. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26073204.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3332_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s13046-023-02893-w","volume":"42","author":"L Zhou","year":"2023","unstructured":"Zhou L, et al. Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma. J Exp Clin Cancer Res. 2023;42(1):311.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"3332_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.ajhg.2018.10.019","volume":"103","author":"WB Dobyns","year":"2018","unstructured":"Dobyns WB, et al. MACF1 mutations encoding highly conserved zinc-binding residues of the GAR domain cause defects in neuronal migration and axon guidance. Am J Hum Genet. 2018;103(6):1009\u201321.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3332_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3332_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu F, et al. Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6(1):307.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3332_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","volume":"16","author":"MJ Perugorria","year":"2019","unstructured":"Perugorria MJ, et al. Wnt-\u03b2-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(2):121\u201336.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3332_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17(1):46.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3332_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3332_CR24","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1038\/s41467-021-25552-0","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and \u0394Np63. Nat Commun. 2021;12(1):5232.","journal-title":"Nat Commun"},{"key":"3332_CR25","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1038\/ncomms7170","volume":"6","author":"MS Sosa","year":"2015","unstructured":"Sosa MS, et al. NR2F1 controls tumour cell dormancy via SOX9- and RAR\u03b2-driven quiescence programmes. Nat Commun. 2015;6:6170.","journal-title":"Nat Commun"},{"issue":"1","key":"3332_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41398-023-02483-6","volume":"13","author":"D Salem","year":"2023","unstructured":"Salem D, Fecek RJ. Role of microtubule actin crosslinking factor 1 (MACF1) in bipolar disorder pathophysiology and potential in lithium therapeutic mechanism. Transl Psychiatry. 2023;13(1):221.","journal-title":"Transl Psychiatry"},{"key":"3332_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.641727","volume":"9","author":"R Cusseddu","year":"2021","unstructured":"Cusseddu R, Robert A, C\u00f4t\u00e9 JF. Strength through unity: the power of the Mega-Scaffold MACF1. Front Cell Dev Biol. 2021;9:641727.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"3332_CR28","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/s41418-021-00744-9","volume":"28","author":"L Hu","year":"2021","unstructured":"Hu L, et al. MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm. Cell Death Differ. 2021;28(7):2160\u201378.","journal-title":"Cell Death Differ"},{"issue":"43","key":"3332_CR29","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3332_CR30","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo S, Dupont S, Cordenonsi M. The biology of YAP\/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94(4):1287\u2013312.","journal-title":"Physiol Rev"},{"issue":"9","key":"3332_CR31","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1158\/0008-5472.CAN-20-2978","volume":"81","author":"T Khan","year":"2021","unstructured":"Khan T, et al. The CDCP1 signaling hub: a target for cancer detection and therapeutic intervention. Cancer Res. 2021;81(9):2259\u201369.","journal-title":"Cancer Res"},{"issue":"8","key":"3332_CR32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nrurol.2012.116","volume":"9","author":"RM Kypta","year":"2012","unstructured":"Kypta RM, Waxman J. Wnt\/\u03b2-catenin signalling in prostate cancer. Nat Rev Urol. 2012;9(8):418\u201328.","journal-title":"Nat Rev Urol"},{"issue":"7","key":"3332_CR33","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nm.1982","volume":"15","author":"L Gattinoni","year":"2009","unstructured":"Gattinoni L, et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med. 2009;15(7):808\u201313.","journal-title":"Nat Med"},{"issue":"8","key":"3332_CR34","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ncb3205","volume":"17","author":"C Patsch","year":"2015","unstructured":"Patsch C, et al. Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol. 2015;17(8):994\u20131003.","journal-title":"Nat Cell Biol"},{"key":"3332_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae195","author":"K Wang","year":"2024","unstructured":"Wang K, et al. BERT-TFBS: a novel BERT-based model for predicting transcription factor binding sites by transfer learning. Brief Bioinform. 2024. https:\/\/doi.org\/10.1093\/bib\/bbae195.","journal-title":"Brief Bioinform"},{"issue":"D1","key":"3332_CR36","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han H, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46(D1):D380-d386.","journal-title":"Nucleic Acids Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03332-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03332-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03332-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:25:19Z","timestamp":1760617519000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03332-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3332"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03332-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were conducted in accordance with the ARRIVE 2.0 guidelines. All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Zhongda Hospital, School of Medicine, Southeast University (Approval No: 20230801003). Mice were randomly allocated to experimental groups using a random number generator. Investigators responsible for tumor measurements, histological evaluation, and metastatic nodule counting were blinded to group allocation during data collection and analysis. Group sizes (n\u2009=\u20096\u20138 per condition) were determined based on prior studies and ensured adequate statistical power while minimizing animal use. Humane endpoints were applied, and no animals were excluded from analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"988"}}